Concord, MA, United States of America

Charles Farnsworth

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Charles Farnsworth

Introduction

Charles Farnsworth is a notable inventor based in Concord, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein phosphorylation. With a total of 2 patents to his name, Farnsworth's work has implications for cancer research and diagnostics.

Latest Patents

Farnsworth's latest patents include groundbreaking inventions related to tyrosine phosphorylation sites. The first patent discloses 482 novel phosphorylation sites identified in carcinoma and/or leukemia. It includes peptides, such as AQUA peptides, that comprise a phosphorylation site, as well as antibodies that specifically bind to these novel sites. The patent also outlines diagnostic and therapeutic uses for these discoveries.

The second patent focuses on reagents for the detection of protein phosphorylation in EGFR-signaling pathways. This invention reveals 168 novel phosphorylation sites identified in signal transduction proteins and pathways downstream of EGFR kinase. It provides phosphorylation-site specific antibodies and heavy-isotope labeled peptides for the selective detection and quantification of these phosphorylated sites and proteins. The patent also details methods for using these reagents effectively.

Career Highlights

Farnsworth is currently associated with Cell Signaling Technology, Inc., where he continues to advance research in protein signaling and cancer biology. His work has been instrumental in developing tools that aid in the understanding of complex cellular processes.

Collaborations

Farnsworth collaborates with talented individuals such as Ailan Guo and Klarisa Rikova, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Charles Farnsworth's contributions to the field of biotechnology through his patents on phosphorylation sites are paving the way for advancements in cancer diagnostics and therapeutics. His work exemplifies the impact of innovative research in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…